S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
Closing prices for crude oil, gold and other commodities
How major US stock indexes fared Friday, 12/8/2023
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
MarketBeat Week in Review – 12/4 - 12/8

Trinity Biotech Stock Price, News & Analysis (NASDAQ:TRIB)

$0.55
+0.04 (+7.84%)
(As of 12/8/2023 ET)
Compare
Today's Range
$0.50
$0.55
50-Day Range
$0.39
$0.74
52-Week Range
$0.37
$1.29
Volume
38,204 shs
Average Volume
47,870 shs
Market Capitalization
$20.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TRIB stock logo

About Trinity Biotech Stock (NASDAQ:TRIB)

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

TRIB Stock Price History

TRIB Stock News Headlines

StockNews.com Initiates Coverage on Trinity Biotech (NASDAQ:TRIB)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Trinity Biotech Announces Q2 2023 Financial Results
See More Headlines
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/03/2023
Today
12/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRIB
Employees
398
Year Founded
1992

Profitability

Net Income
$-41,010,000.00
Pretax Margin
-64.52%

Debt

Sales & Book Value

Annual Sales
$72.42 million
Book Value
($0.06) per share

Miscellaneous

Free Float
34,983,000
Market Cap
$20.96 million
Optionable
Optionable
Beta
1.41

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Aris Kekedjian (Age 56)
    CEO & Chairman
    Comp: $387k
  • Mr. Ronan O'Caoimh (Age 67)
    Founder & Director
    Comp: $340k
  • Mr. John Gillard (Age 42)
    CFO, Company Secretary & Executive Director
    Comp: $863k
  • Dr. James Walsh Ph.D. (Age 65)
    Executive Director of Business Development & Executive Director
    Comp: $20k
  • Mr. Simon Dunne (Age 49)
    Chief Accounting Officer
  • Dr. Gary Keating Ph.D. (Age 50)
    Chief Technology Officer
  • Ms. Eibhlin Kelly (Age 39)
    Chief Information Officer
  • Mr. Colm Molloy (Age 52)
    Group Director of Human Resources & Culture














TRIB Stock Analysis - Frequently Asked Questions

How have TRIB shares performed in 2023?

Trinity Biotech's stock was trading at $0.99 at the beginning of the year. Since then, TRIB stock has decreased by 44.4% and is now trading at $0.55.
View the best growth stocks for 2023 here
.

Are investors shorting Trinity Biotech?

Trinity Biotech saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 59,700 shares, an increase of 70.1% from the October 31st total of 35,100 shares. Based on an average trading volume of 27,600 shares, the short-interest ratio is presently 2.2 days.
View Trinity Biotech's Short Interest
.

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) released its earnings results on Tuesday, October, 3rd. The company reported ($0.20) EPS for the quarter. The business earned $13.90 million during the quarter. Trinity Biotech had a negative trailing twelve-month return on equity of 870.11% and a negative net margin of 46.51%.

What guidance has Trinity Biotech issued on next quarter's earnings?

Trinity Biotech issued an update on its third quarter 2023 earnings guidance on Tuesday, October, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.00 million-$15.00 million, compared to the consensus revenue estimate of $15.00 million.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

Who are Trinity Biotech's major shareholders?

Trinity Biotech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:TRIB) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -